News

Article

HTG Molecular Diagnostics Expands Collaboration with Merck KGaA

The companies have entered an agreement involving assay development and the manufacturing of kits supporting biomarker research programs.

On Dec. 26, 2017, HTG Molecular Diagnostics, a provider of instruments, reagents, and services for molecular profiling applications, announced that it has entered into a new master collaboration agreement with Merck KGaA, Darmstadt, Germany.

According to HTG, this master collaboration agreement complements a previously announced master companion diagnostic agreement with Merck KGaA and includes a statement of work with EMD Serono, the biopharmaceutical business of Merck KGaA in the United States and Canada.

Under the terms of the agreement, HTG plans to develop and manufacture a custom profiling assay to support biomarker research for six indications within Merck KGaA’s drug development pipeline.  The assay is expected to be kitted for use on HTG EdgeSeq instruments acquired by Merck KGaA and/or their contract research organization partners.

“We are pleased to expand our relationship with Merck KGaA, Darmstadt, Germany, into earlier research stages of their programs, and have already begun work on an initial custom assay development program,” said TJ Johnson, president and CEO at HTG, in a company press release.

Source: HTG Molecular Diagnostics

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content